From Genentech – Oncology R&D Division Template by David Nagy · Templates

📂 SECTION 1: 🔬 Preclinical Research

Published 2026-05-01

📄 Target Biology Overview

KRAS mutation pathways
Mechanism of action (GRX-417)
Competitive landscape

📄 In Vitro Studies

Cell line experiments
Drug potency metrics (IC50)
Comparative results

📄 In Vivo Models

Mouse model studies
Tumor shrinkage data
Toxicity observations

📄 Preclinical Conclusions

Go/no-go decisions
Risks identified